Trials / Unknown
UnknownNCT05828238
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
PET Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Affiliated Hospital of Jiangnan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm study to determining the value of apoptotic molecular probe SF-DEVD-2 in the early evaluation of tumor efficacy and comparing it head-to-head wihe 18F-FDG(18F-2-fluoro-2-deoxy-D-glucose)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [18F]SF-DEVD-2 | Patients will receive a tracer dose of 18F (2-4mCi) labelled SF-DEVD-2 |
| DRUG | [18F]-FDG | Patients will receive a tracer dose of 18F (5-10mCi) labelled FDG |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2023-04-25
- Last updated
- 2023-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05828238. Inclusion in this directory is not an endorsement.